Lana Asanin of Corporate Profile reports on Pluristem (PSTI)


Lana Asanin of Corporate Profile reports on Pluristem (PSTI)

About the author

1 Response
  1. admin

    Press Release Source: Pluristem Therapeutics Inc. On Monday June 13, 2011, 8:00 am EDT

    HAIFA, Israel, June 13, 2011 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI – News) (TASE:PLTR – News) today announced that according to the TASE announcement, its ordinary shares will be added to the Mid-Cap-50 Index on the TASE, beginning on June 15, 2011. The Mid-Cap-50 Index includes the 50 shares with the highest market capitalization that are not included in the TA-100 index.

    Following the inclusion in the Mid-Cap-50 the company’s ordinary shares will be included in the following TASE equity indexes: Biomed Index, Mid-Cap-50 TA Index, TA BlueTech-50 Index, TA Composite Index, Shares Index and the Industry Index.

    About Pluistem Therapeutics Inc.

    For more information about Pluristem Therapeutics Inc. (Nasdaq:PSTI – News) (TASE:PLTR – News) visit http://www.pluristem.com, the content of which is not part of this press release. Follow Pluristem on Twitter@Pluristem.

    The Pluristem Therapeutics Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=6882

Leave a Reply